Soverini, S., De Benedittis, C., Polakova, K. M., Linhartova, J., Castagnetti, F., Gugliotta, G., . . . Martinelli, G. (2016). Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients. Oncotarget.
Styl cytowania ChicagoSoverini, Simona, et al. "Next-generation Sequencing for Sensitive Detection of BCR-ABL1 Mutations Relevant to Tyrosine Kinase Inhibitor Choice in Imatinib-resistant Patients." Oncotarget 2016.
Styl cytowania MLASoverini, Simona, et al. "Next-generation Sequencing for Sensitive Detection of BCR-ABL1 Mutations Relevant to Tyrosine Kinase Inhibitor Choice in Imatinib-resistant Patients." Oncotarget 2016.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..